Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,75 USD | +1,16% | -0,57% | +19,05% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. rapporteert winstresultaten voor het vierde kwartaal eindigend op 31 december 2023 | CI |
Omzet 2024 * | 48,23 mln. 44,71 mln. | Omzet 2025 * | 47,83 mln. 44,34 mln. | Marktkapitalisatie | 94,27 mln. 87,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -53 mln. -49,13 mln. | Nettowinst (verlies) 2025 * | -62 mln. -57,47 mln. | EV/omzet 2024 * | 1,95 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,97 x |
K/w-verhouding 2024 * |
-1,87
x | K/w-verhouding 2025 * |
-1,84
x | Werknemers | 46 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 79,65% |
Recentste transcriptie over Spero Therapeutics, Inc.
1 dag | +1,16% | ||
1 week | -0,57% | ||
Lopende maand | +6,06% | ||
1 maand | +6,71% | ||
3 maanden | +25,00% | ||
6 maanden | +45,83% | ||
Lopend jaar | +19,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 04-01-21 |
Ankit Mahadevia
FOU | Founder | 43 | 01-04-13 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | 06/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 01-07-17 |
John Pottage
BRD | Director/Board Member | 71 | 14-08-18 |
Scott Jackson
BRD | Director/Board Member | 59 | 16-04-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 1,75 | +1,16% | 371 566 |
26-03-24 | 1,73 | +2,37% | 217 332 |
25-03-24 | 1,69 | -3,43% | 261 209 |
22-03-24 | 1,75 | +1,16% | 170 147 |
21-03-24 | 1,73 | -1,70% | 255 023 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,05% | 94,27 mln. | |
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+7,74% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |